Jan 17 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab said a higher dose of its drug Wegovy led to greater weight loss in patients during a late-stage trial, but the results fell short of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback